In brief
Health officials are probing a surge in infant botulism cases linked to ByHeart baby formula, with over 30 instances reported since August. Parents of affected infants from prior months are demanding transparency and answers regarding the safety and sources of the illness. The investigation has revealed that multiple babies hospitalized before the current outbreak were also fed ByHeart formula. As parents await clarity, health officials are focusing on the outbreak, acknowledging the rarity and potential severity of botulism in infants.
As health officials investigate more than 30 cases of infant botulism linked to ByHeart baby formula since August, parents whose infants were sickened months prior are voicing their concerns. California public health officials confirmed late Friday that six babies who consumed ByHeart formula were treated for botulism between November 2024 and June 2025, several months before the current outbreak that has sickened at least 31 infants across 15 states.
Health officials indicated there wasn't enough evidence to initially connect earlier cases to ByHeart formula. Yet, the growing concern among parents has prompted calls for answers and accountability. Amy Mazziotti, from Burbank, reported her son Hank hospitalized for botulism shortly after consuming the formula. Similarly, Katie Connolly’s daughter M.C. faced hospitalization after being fed ByHeart formula, also leading to concerns about the product's safety.
After months of ambiguous health alerts, ByHeart recalled all its products nationwide on November 11 in connection with escalating botulism cases. Following this, laboratory tests confirmed some unopened formula samples were contaminated with bacteria associated with infant botulism.
The CDC is now focusing its efforts on understanding the recent upsurge in botulism cases, acknowledging the need for further investigation into earlier reported illnesses. Meanwhile, affected parents like Connolly and Mazziotti demand transparency about how their infants contracted botulism if earlier cases were overlooked.
Health officials highlighted the rarity of infant botulism in the U.S., with under 200 cases reported annually. The condition typically results from spores ingested and producing toxins in the baby's gut. As investigations continue, the uncertainty surrounding safety and accountability weighs heavily on families.
